The Evaluation of the Patient Undergoing an Elective Transjugular Intrahepatic Portosystemic Shunt Procedure

ABSTRACT

In its early stages, the transjugular intrahepatic portosystemic shunt (TIPS) was utilized as a lifesaving procedure to treat uncontrollable esophageal variceal bleeding. Most of the initial cases were performed in an emergency situation in the worst possible conditions. The experience gained over the past 15 years has established TIPS as an important therapeutic option in the management of patients with complications of portal hypertension such as variceal bleeding or refractory ascites who do not respond to medical therapy. In current medical practice, 80 to 90% of TIPS procedures are performed in an elective or semielective fashion and only a small percentage of cases are now performed on an emergency basis. The experience gained has demonstrated that certain patients do not benefit from a TIPS procedure and furthermore, their baseline condition may even worsen after a TIPS. This article reviews the most important aspects of the clinical evaluation of patients undergoing an elective TIPS procedure.

KEYWORDS

MELD score - portal hypertension - Child-Pugh score - transjugular intrahepatic portosystemic shunts

REFERENCES

• 1 Richter G M, Noeldge G, Palmaz J C, Roessle M. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): results of a pilot study.  Cardiovasc Intervent Radiol. 1990;  13 200-207
• 2 Zemel G, Katzen B T, Becker G J, Benenati J F, Sallee D S. Percutaneous transjugular portosystemic shunt.  JAMA. 1991;  266 390-393
• 3 Helton W S, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS).  Am J Surg. 1993;  165 566-571
• 4 Freedman A M, Sanyal A J, Tisnado J et al.. Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review.  Radiographics. 1993;  13 1185-1210
• 5 Shiffman M L, Jeffers L, Hoofnagle J H, Tralka T S. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board.  Hepatology. 1995;  22 1591-1597
• 6 Tyburski J G, Noorily M J, Wilson R F. Prognostic factors with the use of the transjugular intrahepatic portosystemic shunt for bleeding varices.  Arch Surg. 1997;  132 626-630 discussion 630-622
• 7 Sanyal A J, Genning C, Reddy K R et al.. The North American Study for the treatment of refractory ascites.  Gastroenterology. 2003;  124 634-641
• 8 Rosch J, Keller F S. Transjugular intrahepatic portosystemic shunt: present status, comparison with endoscopic therapy and shunt surgery, and future prospectives.  World J Surg. 2001;  25 337-345 discussion 345-336
• 9 Boyer T D, Haskal Z J. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.  Hepatology. 2005;  41 386-400
• 10 Patch D, Nikolopoulou V, McCormick A et al.. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding.  J Hepatol. 1998;  28 454-460
• 11 Malinchoc M, Kamath P S, Gordon F D, Peine C J, Rank J, ter Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.  Hepatology. 2000;  31 864-871
• 12 Bilbao J I, Pueyo J C, Longo J M et al.. Interventional therapeutic techniques in Budd-Chiari syndrome.  Cardiovasc Intervent Radiol. 1997;  20 112-119
• 13 Spencer E B, Cohen D T, Darcy M D. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax.  J Vasc Interv Radiol. 2002;  13 385-390
• 14 Guevara M, Gines P, Bandi J C et al.. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.  Hepatology. 1998;  28 416-422
• 15 Selim K M, Akriviadis E A, Zuckerman E, Chen D, Reynolds T B. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome.  Am J Gastroenterol. 1998;  93 455-458
• 16 Haskal Z J, Scott M, Rubin R A, Cope C. Intestinal varices: treatment with the transjugular intrahepatic portosystemic shunt.  Radiology. 1994;  191 183-187
• 17 Boyer T D. Transjugular intrahepatic portosystemic shunt: current status.  Gastroenterology. 2003;  124 1700-1710
• 18 Ferral H, Patel N H. Selection criteria for patients undergoing transjugular intrahepatic portosystemic shunt procedures: current status.  J Vasc Interv Radiol. 2005;  16 449-455
• 19 Haskal Z J, Rees C R, Ring E J, Saxon R, Sacks D. Reporting standards for transjugular intrahepatic portosystemic shunts. Technology Assessment Committee of the SCVIR.  J Vasc Interv Radiol. 1997;  8 289-297
• 20 Pugh R N, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R. Transection of the oesophagus for bleeding oesophageal varices.  Br J Surg. 1973;  60 646-649
• 21 Forman L M, Lucey M R. Predicting the prognosis of chronic liver disease: an evolution from child to MELD.  Hepatology. 2001;  33 473-475
• 22 Schepke M, Roth F, Fimmers R et al.. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.  Am J Gastroenterol. 2003;  98 1167-1174
• 23 Angermayr B, Cejna M, Karnel F et al.. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.  Gut. 2003;  52 879-885
• 24 Encarnacion C E, Palmaz J C, Rivera F J et al.. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality.  J Vasc Interv Radiol. 1995;  6 687-694
• 25 Rubin R A, Haskal Z J, O'Brien C B, Cope C, Brass C A. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores.  Am J Gastroenterol. 1995;  90 556-563
• 26 Banares R, Casado M, Rodriguez-Laiz J M et al.. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.  Am J Gastroenterol. 1998;  93 75-79
• 27 Salerno F, Merli M, Cazzaniga M et al.. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.  J Hepatol. 2002;  36 494-500
• 28 Ferral H, Vasan R, Speeg K V et al.. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures.  J Vasc Interv Radiol. 2002;  13 1103-1108
• 29 Kamath P S, Wiesner R H, Malinchoc M et al.. A model to predict survival in patients with end-stage liver disease [see comments].  Hepatology. 2001;  33 464-470
• 30 Wiesner R H, McDiarmid S V, Kamath P S et al.. MELD and PELD: application of survival models to liver allocation.  Liver Transpl. 2001;  7 567-580
• 31 Said A, Williams J, Holden J et al.. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.  J Hepatol. 2004;  40 897-903
• 32 Ferral H, Gamboa P, Postoak D W et al.. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.  Radiology. 2004;  231 231-236